Other
HBV Infection
1
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
HBV Infection is an early-stage landscape with 1 program across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
6
clinical trials
Completed2 · 33%
Not yet recruiting2 · 33%
Recruiting1 · 17%
Active, not recruiting1 · 17%
Clinical Trials
Trial Activity
6 trials
Antiviral Therapy in Infants With HBV Infection
Not yet recruiting·—·Phase 4·NCT06503796·60 enrolled
Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 Injection in Patients With Chronic Hepatitis B
Not yet recruiting·GGrand Theravac Life Sciences (Nanjing) Co., Ltd.·Phase 1·NCT07673068·32 enrolled
A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection
Completed·TThe HIV Netherlands Australia Thailand Research Collaboration·N/A·NCT00476411·200 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)